share_log

D. Boral Capital Initiates Coverage On CervoMed With Buy Rating, Announces Price Target of $34

Benzinga ·  Nov 18 10:16  · Ratings

D. Boral Capital analyst Jason Kolbert initiates coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and announces Price Target of $34.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment